Financial Results
Sangam Health Care Products Reports H1 FY27 Results
Sangam Health Care Products approved unaudited financial results and the limited review report for the quarter and half year ended September 30, 2026.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Upcoming Result Date: Today
this company is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
this company operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, this company has traded between a low of ₹0.00 and a high of ₹0.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
this company has a market capitalization of approximately N/A. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
this company’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of N/A and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of N/A Cr, this company is classified as a N/A stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
this company operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of this company is N/A. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Sangam Health Care Products reported profit after tax of Rs 65.88 lakh for the half year ended 30 September 2026. This compared with Rs 33.62 lakh for the corresponding half year ended 30 September 2025, an increase of Rs 32.26 lakh.
Sangam Health Care Products reported total equity of negative Rs 19.19 crore at September 30, 2026. Equity share capital of Rs 14.86 crore was offset by negative other equity of Rs 34.05 crore.
Sangam reported consolidated profit after tax of Rs 53.40 crore for Q2 FY27. This was 130.87% higher than Rs 23.13 crore reported in Q2 FY26.